Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NHL-BFM-90 Regimen

Known as: BFM-90 Regimen 
A regimen used for the treatment of localized aggressive forms of childhood B-cell non-Hodgkin's lymphoma, including lymphoblastic lymphoma.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Objective: To evaluate the efficacy and safety of rituximab combined with the modified NHL-BFM-90 protocol in childhood and… Expand
Is this relevant?
Review
2018
Review
2018
Diffuse large B-cell lymphoma is categorized by gene expression profiling into germinal center (GCB) and activated B-cell (ABC… Expand
Is this relevant?
2017
2017
Objective Although L-asparaginase (L-ASP) is a standard treatment for lymphoblastic lymphoma (LBL), hypersensitivity reactions by… Expand
  • table 2
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2014
2014
The aim of this work was assessment of the brain functional state and to find an electroencephalogramm (EEG)-predictors of… Expand
Is this relevant?
2009
2009
AIM To evaluate efficacy of intensive modified program NHL-BFM-90 (mNHL-BFM-90) in adult poor-prognosis patients with diffuse… Expand
Is this relevant?
2007
2007
OBJECTIVE This study was designed to evaluate the efficacy and toxicity of modified BFM-90 regimen originated from Germany… Expand
Is this relevant?